Transcriptomics

Dataset Information

0

Impact of the menstrual cycle and ethinyl estradiol/etonogestrel contraceptive vaginal ring on granulysin and other mucosal immune mediators


ABSTRACT: We conducted a prospective, open-label study to determine the effect of the NuvaRing on gene expression in the endocervix and immune-related protein expression in cervicovaginal secretions. Women provided endocervical cytobrush samples during the luteal and follicular phases of the menstrual cycle (as determined by progesterone levels) as well as during NuvaRing use. Gene expression was measured using Illumina Human HT12 v4 BeadChip microarrays. We compared the NuvaRing visit to each phase of the menstrual cycle separately, as well as follicular and luteal phase samples to each other, adjusting for technical batch, presence of blood in vaginal discharge, and BV status by Nugent score, and blocking on participant. We found that gene expression in the endocervical canal changed across the menstrual cycle and in response to NuvaRing use. In particular, we observed a continuum of expression of immune-related genes and gene sets in the endocervical canal: highest during NuvaRing use, intermediate in the follicular phase, and lowest in the luteal phase.

ORGANISM(S): Homo sapiens

PROVIDER: GSE142058 | GEO | 2020/12/30

REPOSITORIES: GEO

Dataset's files

Source:
Action DRS
Other
Items per page:
1 - 1 of 1

Similar Datasets

2020-06-07 | GSE99800 | GEO
2023-03-30 | GSE183771 | GEO
2015-07-08 | E-GEOD-68079 | biostudies-arrayexpress
2016-05-12 | GSE80455 | GEO
| PRJNA318970 | ENA
2013-08-30 | E-GEOD-33805 | biostudies-arrayexpress
2013-05-09 | E-GEOD-46735 | biostudies-arrayexpress
2015-07-08 | GSE68079 | GEO
2013-08-30 | GSE33805 | GEO
2023-07-20 | PXD038002 | Pride